基础医学与临床 ›› 2016, Vol. 36 ›› Issue (4): 526-530.

• 临床园地 • 上一篇    下一篇

组合性肾上腺髓质肿瘤的临床特点分析

吴兴成1,纪志刚2,李汉忠2,严维刚3,石冰冰4,肖雨1   

  1. 1. 北京协和医院
    2. 中国医学科学院 北京协和医学院 北京协和医院泌尿外科
    3. 北京协和医院泌尿科
    4. 北京协和医院泌尿外科
  • 收稿日期:2015-11-17 修回日期:2015-12-28 出版日期:2016-04-05 发布日期:2016-03-29
  • 通讯作者: 纪志刚 E-mail:jizhigang@163.com

Clinical characteristics of composite adrenal medullary tumor

  • Received:2015-11-17 Revised:2015-12-28 Online:2016-04-05 Published:2016-03-29

摘要: 目的 探讨组合性肾上腺髓质肿瘤(嗜铬细胞瘤Pheo-节细胞神经瘤Gn)的临床特点、治疗和预后。 方法 回顾性分析11例组合性肾上腺髓质肿瘤的临床资料,总结临床表现、实验室检查、辅助检查及病理组织学结果,定期门诊随诊复查。 结果 男性6例,女性5例,年龄37~63岁。临床表现:高血压10例,伴有阵发性心悸3例,血压正常1例。24h尿儿茶酚胺检查,9例升高,2例正常,其中6例多巴胺升高。肿瘤均为单发,左侧4例,右侧7例,直径2.2~16.4cm,平均5.8cm,CT提示肿瘤呈不均质强化,其中6例病变内有囊性变。9例行99Tcm-奥曲肽显像,其中5例阳性;5例行131I-间位碘代苄胍显像检查,均为阳性。术前α受体阻滞剂准备2~4周。9例行后腹腔镜下肾上腺肿瘤切除术,1例行腹腔镜转开放手术切除,1例行开放手术切除。病理报告均为组合性嗜铬细胞瘤(Pheo-Gn)。11例随访10~136个月,平均68个月,10例高血压患者9例恢复正常,肿瘤未见复发、转移。结论 组合性肾上腺髓质肿瘤临床罕见,临床表现与嗜铬细胞瘤类似,多数为有功能的肿瘤,病理为目前唯一确诊手段,手术切除是治疗最佳选择,不伴恶性成分者预后良好。

关键词: 肾上腺肿瘤, 组合性嗜铬细胞瘤, 节细胞神经瘤

Abstract: Objective To investigate the clinical characteristics, management and prognosis of composite adrenal medullary tumor(pheochromocytoma-ganglioneuroma). Methods Eleven cases of composite adrenal medullary tumor were retrospectively analyzed on clinical materials. Summarize clinical manifestation, laboratory examinations, assistant examinations and pathological histology results, their follow-up data were got throμgh outpatient. Results Six cases were male,another five cases were female,aged 37 to 63 years.Ten of them had the history of hypertension,three of them accompanied with paroxysmal palpitation, while one case without any symptom.Twenty-four hours urinary catecholamine examination revealed that nine cases were at elevated level and the others were normal,the level of dopamine was elevated in six cases. Computerized tomography(CT) showed single tumor in adrenal gland, four cases in left, another seven cases in right. The diameter was 2.2 to 16.4cm, average 5.8cm. CT demonstrated that these tumours were heterogeneous and there was significant enhancement on postcontrast phase. Six cases had cystic components. Five of nine cases showed positive result in 99mTc-hydrazinonicotinamide-3 trypsin octreotide (HTOC) scintigraphy. Five cases all showed positive results in 131I-metaiodobenzylguanidine (MIBG) scintigraphy. Ten cases were managed with α-adrenergic receptor blocker preoperatively for 2 to 4 weeks. Tumor resection was performed in all 11 cases, and ten cases by retroperitoneal laparoscopy, one by open surgery. All 11 cases were diagnosed as composite pheochromocytoma of adrenal(Pheochromocytoma-ganglioneuroma) by pathology. All patients had no evidence of recurrence or metastasis during follow-up from 10 to 136 months.Nine of ten cases with hypertension reverted to normotensive. Conclusions Composite pheochromocytoma of adrenal is rare, difficult to be diagnosed preoperatively. Most cases were functional. Biopsy is the only accurate diagnostic method.Surgical resection is the best choice for treatment.Without malignant component, composite pheochromocytoma shows favourable prognosis.

Key words: adrenal gland neoplasms, composite pheochromocytoma, ganglioneuroma

中图分类号: